Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion?
| Autor: | Adamo, Marianna, Chiari, Ermanna, Curello, Salvatore, Maiandi, Cristian, Chizzola, Giuliano, Fiorina, Claudia, Frontini, Mario, Cuminetti, Giovanni, Pezzotti, Elena, Rovetta, Riccardo, Lombardi, Carlo Mario, Manzato, Aldo, Metra, Marco, Ettori, Federica |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Heart Valve Prosthesis Implantation
Male Mitraclip implantation Mitral Valve Insufficiency Functional mitral regurgitation Leaflet coaptation Long-term outcome Middle Aged Surgical Instruments Heart Valves Treatment Outcome Heart Valve Prosthesis Humans Mitral Valve Female Aged Retrospective Studies |
| Zdroj: | European journal of heart failure. 18(10) |
| ISSN: | 1879-0844 |
| Popis: | The aim of this study was to investigate the feasibility, safety, and efficacy of Mitraclip therapy in patients with functional mitral regurgitation (MR) and missing leaflet coaptation (MLC).Out of 62 consecutive patients with functional MR undergoing Mitraclip implantation, 22 had MLC defined as the presence of a 'gap' between two mitral leaflets or insufficient coaptation length (2 mm), according to the EVEREST II criterion. Compared with the control group, the MLC population had a significantly higher effective regurgitant orifice area (0.67 ± 0.31 vs. 0.41 ± 0.13 cmThe Mitraclip procedure could be extended to patients with functional MR who do not fulfil the coaptation length EVEREST II criterion and who would otherwise be excluded from this treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text